Last updated: 11/07/2018 14:13:58
A Double-blind, Placebo-controlled, Flexible-dose Study of Paroxetine CR in the Treatment of Patients with Social Anxiety Disorder
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Double-blind, Placebo-controlled, Flexible-dose Study of Paroxetine CR in the Treatment of Patients with Social Anxiety Disorder
Trial description: A Double-blind, Placebo-controlled, Flexible-dose Study of Paroxetine CR in the Treatment of Patients with Social Anxiety Disorder
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Efficacy of controlled- release paroxetine in the treatment of patients with social anxiety disorder. St.Lambert, Jane Ph. D., Rasmussen, Siig M. D., Ruggiero, Lee D. B. S., and Rolfe, Timothy E. M. Sc 156th Annual Meeting of the American Psychiatric Association 5/17/2003 San Francisco, CA; USA
Improvement of functional impairment in patients with social anxiety disorder. Ruggiero, Lee D. B. S., Rasmussen, Siig M. D., St. Lambert, Jane Ph. D., and Rolfe, Timothy E. M. Sc. 156th Annual Meeting of the American Psychiatric Association 5/17/2003 San Francisco, CA; USA
Lepola et al. (2004) Controlled-release paroxetine in the treatment of patients with Social Anxiety Disorder. J Clin Psych 65: 222-229.
Paroxetine cr in the treatment of patients with social anxiety disorder. Ruggiero, Lee B. S. 23rd Annual Conference of the Anxiety Disorders Association of America 3/27/2003 Toronto, ON; Canada
Medical condition
Social Phobia
Product
paroxetine
Collaborators
Not applicable
Study date(s)
October 2001 to July 2002
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2002-03-07
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website